P392-2055 Screening compound: N,N-dimethyl-2-({1-[(3,4,5-trimethoxyphenyl)carbamoyl]pyrrolidin-3-yl}oxy)pyridine-3-carboxamide

P392-2055 Screening compound: N,N-dimethyl-2-({1-[(3,4,5-trimethoxyphenyl)carbamoyl]pyrrolidin-3-yl}oxy)pyridine-3-carboxamide
P392-2055 Screening compound: N,N-dimethyl-2-({1-[(3,4,5-trimethoxyphenyl)carbamoyl]pyrrolidin-3-yl}oxy)pyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P392-2055
N,N-dimethyl-2-({1-[(3,4,5-trimethoxyphenyl)carbamoyl]pyrrolidin-3-yl}oxy)pyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P392-2055

Molecular Formula

C22H28N4O6 (C22 H28 N4 O6)

Compound Name

N,N-dimethyl-2-({1-[(3,4,5-trimethoxyphenyl)carbamoyl]pyrrolidin-3-yl}oxy)pyridine-3-carboxamide

IUPAC name

NN-dimethyl-2-({1-[(345-trimethoxyphenyl)carbamoyl]pyrrolidin-3-yl}oxy)pyridine-3-carboxamide

SMILES

CN(C)C(c1cccnc1OC(CC1)CN1C(Nc(cc1OC)cc(OC)c1OC)=O)=O

InChI

InChI=1S/C22H28N4O6/c1-25(2)21(27)16-7-6-9-23-20(16)32-15-8-10-26(13-15)22(28)24-14-11-17(29-3)19(31-5)18(12-14)30-4/h6-7,9,11-12,15H,8,10,13H2,1-5H3,(H,24,28)/t15-/m1/s1

InChI Key

ADHQTNGWJCSKNG-OAHLLOKOSA-N

MDL Number (MFCD)

MFCD28999184

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

444.49

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.724

Distribution Coefficient, logD

0.724

Water Solubility, LogSw

-2.08

Polar Surface Area

81.052

Acid Dissociation Constant (pKa)

11.74

Base Dissociation Constant (pKb)

0.67

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.90

P392-2055 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • Ion Channels
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P392-2055 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P392-2055?
Check Price and Availability of P392-2055, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P392-2055 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P392-2055
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P392-2055
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P392-2055 available by request